The neurologists and neurosurgeons at Torrance Memorial Medical Center
are committed to providing leading-edge care for people with neurological
conditions that affect the brain, spine, and nervous system. Through our
affiliation with the neurology and neurosurgery team at Cedars-Sinai,
Torrance Memorial patients have access to a full range of Cedars-Sinai
clinical trials for a variety of neurological conditions.
Advanced Clinical Trials
Specialists at the Lundquist Neurosciences Institute participate in the
latest research, including clinical trials to advance stroke treatment:
WISP study – A new vessel wall imaging-based stroke registry which investigates
the clinical utility of the whole-brain intracranial vessel wall magnetic
resonance imaging (MRI) technique in assessing the etiologies in patients
with ischemic stroke.
TIMELESS study – Patients receive study drug tenecteplase (or placebo), a one-time
drug with a longer half-life than the standard stroke thrombolytic, allowing
for a single bolus administration.
CREST-2 trial – CREST-2 compares three different methods of stroke prevention to
find the safest and most effective treatment – intensive medical
management alone; intensive medical management in combination with carotid
endarterectomy; intensive medical management with carotid stenting. (NOTE:
Available at Cedars-Sinai Medical Center only. Torrance Memorial Medical
Center eligible subjects can enroll in the trial.)